The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Amara CS, Kami Reddy KR, Yuntao Y, Chan YS, et al. Nat Commun 2024;15:1373.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Amara CS, Kami Reddy KR, Yuntao Y, Chan YS, et al. The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nat Commun 2024;15:1373.
PMID: 38355560